DNYS Cyber-Thingy™ Executes Distribution Agreement With

New Post Public Reply Private Reply Replies (0) Message Board
MicroCapStocksRock DOLLARLAND #7027

DNYS Cyber-Thingy™ Executes Distribution Agreement With American First Equity Inc. To Place 1,000 Kiosk Machines

Cyber-Thingy™ Executes Distribution Agreement With American First Equity Inc. To Place 1,000 Kiosk Machines

THE DISTRIBUTION AGREEMENT IS VALUED AT AN ESTIMATED $12,000,000 IN ANNUAL REVENUES FOR CYBER-THINGY™

CORAL SPRINGS, Fla., Jan. 7, 2013 /PRNewswire/ -- Dynasty Limousine, Inc. (PinkSheets: DNYS) is pleased to announce its wholly owned subsidiary Cyber-Thingy™ has executed a distribution agreement with American First Equity, Inc., (a 7.5 year old company in the business of distributing gas, oil, credit card processing services, ATM placement services) to place 1,000 financial kiosks by the end of September 2013.

Once a machine is installed and operational for 3 months, Cyber-Thingy™ will receive a monthly revenue share of approximately $1,000 per month per machine. If there is any kiosk machines that are under-performing, American First Equity Inc. will move them to other more profitable locations.

The terms of the Agreement require Cyber-Thingy™ to deliver 3 fully customized operational machines to American First Equity by the end of January for testing. Once American First Equity has fully tested the machines and all changes are agreed to, Cyber-Thingy™ shall begin delivering 100 machines per month beginning April 1, 2013 for the first 4 months, then 200 machines for the next 3 months ending in September 2013.

One of the unique opportunities offered by the kiosk is that, the Company's software can be updated remotely. Cyber-Thingy™ will also offer distribution to other online service providers that do not have their services offered at these locations which will enhance the revenue generated per machine.

Cyber-Thingy™ will be rebuilding its website to show the additional level of services offered and there will be videos of the machines in operation. The additions to the website will showcase its different kiosk machines, including an Investor Relations section and detail a list of residual products and services offered by the Company in its financial kiosks.

The Company is working on the name change and will follow up with a press release regarding the name change and submission to FINRA later in the week.

About Cyber-Thingy™

Cyber-Thingy™ distributes Company owned kiosk machines and tablets to earn residual revenues and/or sell kiosk machines to earn up-front and residual revenues. Cyber-Thingy's™ multiple revenue streams are derived transaction and fee based programs running within the kiosks such as; Digital Advertising, Mobile Phone Top-up minutes (reload), Online Bill Pay, Sweepstakes Games, Events-Sports-Movie Tickets, Gift Card Programs, Prepaid Cards, Digital Lottery and New Product Launch (ALL with immediate purchasing options). Each Kiosk machine comes with a cash bill acceptor and a credit card reader for ease of payment. Tablets are connected to existing POS systems. These multi-functional kiosks and tablets not only earn Cyber-Thingy™ residual revenues but create residual revenue opportunities for the multiple companies involved.



About American First Equity Inc.

American First Equity Inc. (AFE) is a Hollywood FL based company that focuses on residual markets. AFE offers services in the area of; gas and oil distribution, credit card processing, prepaid debit card programs, ATM placement and factoring. AFE has also acted as servicing agents for mortgage lenders since 2005.


The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.




CONTACT:





Chris Clarke


Investor@cyber-thingy.com

954-509-3748 begin_of_the_skype_highlighting 954-509-3748 FREE end_of_the_skype_highlighting

My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading